Showing results (2131-2140 of 14,098) with videos related to

Sort By:
Pageof 1,410
Gynecologic Oncology|September 13, 2005
Optical imaging of cervical pre-cancers with structured illumination: an integrated approachMohammed Rahman, Muhammad Abd-El-Barr, Vivian Mack, et al.
Gynecologic Oncology|September 20, 2005
Can we do the same in the developing world?Adriana Bermudez
Gynecologic Oncology|September 20, 2005
Germline polymorphism of p53 codon 72 in gynecological cancerMasatsugu Ueda, Yoshito Terai, Koji Kanda, et al.
Gynecologic Oncology|July 12, 2005
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapyMichael G Kelly, David M O'malley, Pei Hui, et al.
Gynecologic Oncology|July 19, 2005
Reconstructive surgery following resection of primary vulvar cancersW Weikel, M Hofmann, E Steiner, et al.
Gynecologic Oncology|August 2, 2005
Large cell lymphoma-like reaction in a cervical polypFrancesc Alameda, Beatriz Bellosillo, Teresa Baró, et al.
Gynecologic Oncology|April 7, 2005
Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancerYasuhiro Shinyo, Junichi Kodama, Hasengaowa, et al.
Gynecologic Oncology|April 1, 1992
Lymphoma of ovary with stromal luteinization, presenting as secondary amenorrheaK R Mittal, A Blechman, M A Greco, et al.
Gynecologic Oncology|May 1, 1992
Long-term results of a randomized trial comparing cisplatin with cisplatin and cyclophosphamide with cisplatin, cyclophosphamide, and adriamycin in advanced ovarian cancer. GICOG (Gruppo Interregionale Cooperativo Oncologico Ginecologia), Italy
Gynecologic Oncology|May 1, 1992
Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patientsJ A Lucci, A Manetta, F Cappuccini, et al.
Pageof 1,410